Introduction
============

The exact cause of inflammatory bowel disease (IBD) remains unclear. Cronus\'s disease (CD) and ulcerative colitis (UC) are the two main types of IBD ([@b1-etm-0-0-5582]). Previous studies have indicated that a genetic predisposition to IBD may exist ([@b2-etm-0-0-5582],[@b3-etm-0-0-5582]). First-degree relatives of patients with IBD were more susceptible to IBD, and sibling patients were identified to have a high concordance of disease type and location ([@b4-etm-0-0-5582]). In addition, a substantially higher disease concordance has been observed for CD and UC in monozygotic twins compared with that in dizygotic twins ([@b5-etm-0-0-5582]). It has also been reported that the pair concordance rate in monozygotic pairs is \~50% ([@b6-etm-0-0-5582]).

Three independent mutations in nucleotide-binding oligomerization domain-containing protein 2 (*NOD2*), namely Arg702Trp, Gly908Arg and Leu1007fsinsC, are the first verified genetic variants to be associated with CD in the Caucasian population ([@b7-etm-0-0-5582],[@b8-etm-0-0-5582]). Mutation of Cys203Tyr in the X-linked inhibitor of apoptosis (*XIAP*) gene has also been indicated to cause immunodeficiency in a child with CD ([@b9-etm-0-0-5582]). In addition, mutations in the interleukin-10 receptor (IL10R) subunit proteins *IL10RA* (Thr84Ile and Gly141Arg) and *IL10RB* (Trp159X) have been associated with early-onset enterocolitis in two unrelated families ([@b10-etm-0-0-5582]).

The incidence and prevalence of IBD used to be high in the western population ([@b11-etm-0-0-5582]), and is now increasing markedly in China ([@b12-etm-0-0-5582],[@b13-etm-0-0-5582]). Controversies have been observed regarding genetic variants in populations in Japan and Hong Kong ([@b14-etm-0-0-5582],[@b15-etm-0-0-5582]). Therefore, reassessment of the role of previously reported single nucleotide polymorphisms in specific populations is required. Few studies have reported familial aggregations in China, and to the best of our knowledge, there is no report of concordant monozygotic twin pairs with CD in China. In the present study, samples were collected from 4 Han Chinese families with a history of IBD, including 8 CD patients and 2 UC sisters, and the distributions of 7 reported genetic variants associated with IBD were investigated. Associations between specific environmental factors and IBD were also analyzed.

Materials and methods
=====================

### Subjects

A total of 100 patients from 4 families were studied, including 54 males and 46 females. Patients were recruited between March 2010 and March 2015. The mean age was 30.3 years old. Patients with enterophthisis suffintestinal tumor were excluded. The familial patients included in the present study were recruited from the Department of Gastroenterology at the Zhongnan Hospital of Wuhan University (Wuhan, China) and the Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases (Wuhan, China). The registered IBD database of the Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases (Wuhan, China) was used to compare familial and sporadic patients. Written informed consent was obtained from all patients in the registered IBD database and the parents of all enrolled children. The present study was approved by the Ethics Committee of the Zhongnan Hospital of Wuhan University as part of the human subjects\' protocol to study the pathogenesis of IBD.

Patients with IBD were all born from non-consanguineous Chinese parents. All diagnoses were made according to the criteria on the basis of clinical, radiological, endoscopic and histological examinations Clinical blood tests included screening for anemia and infection, and the fecal occult blood test was performed to test for blood in the stool. For radiological diagnosis, an iodinated oil solution (Guerbet, Villepinte, France) was used as a contrast medium reveal the contours of the esophagus, stomach, small bowel or colon. Endoscopies were performed to view the entire colon. The optical instrument is introduced through the mouth and advanced through the esophagus into the stomach and duodenum. During the procedure, small samples of tissue were harvested for laboratory analysis to confirm diagnoses. Histological assessments were performed. The histological features were then used to assess the severity of diagnosis, ranging from definite Crohn\'s disease to definite ulcerative colitis ([@b16-etm-0-0-5582]). Demographic data were acquired from reviews of medical records, phone interviews and face-to-face interviews. For each patient, the information collected included: Sex, age, initial diagnosis age, disease extent, disease activity score at diagnosis (using the CD activity index and the UC activity index) ([@b17-etm-0-0-5582],[@b18-etm-0-0-5582]) and treatment history. For family members, the information collected included the following: Sex, age, residence, immigration status, education, occupation, marital status, smoking status, history of other autoimmune diseases, vaccination history and possession of pet animals.

### Pedigrees analysis

The familial patients were identified as having a familial history of IBD when first and/or second-degree relatives also had IBD. A total of 4 Han Chinese families, including 10 familial patients with IBD, were all from Hubei province. The pedigrees of the 4 families were acquired on the basis of epidemiological investigation. Detailed information on the whereabouts and cause of mortality were obtained for each patient. The health conditions of each unaffected family member were assessed by a self-report, telephone inquiry and face-to-face interview.

### Genotyping

Genomic DNA was isolated from EDTA-anticoagulated peripheral venous blood using a QIAamp DNA Blood Midi kit according to the manufacturer\'s protocol (Qiagen GmbH, Hilden, Germany). The genotypes of 7 reported IBD mutations (shown in [Table I](#tI-etm-0-0-5582){ref-type="table"}) were screened by Sanger sequencing of polymerase chain reaction (PCR) products. PCR was performed utilizing PCR amplification kit with Taq DNA polymerases according to manufacturer\'s protocol (New England Biolabs Inc., Ipswich, MA, USA). The PCR was performed as follows: 95°C for 5 min followed by 30 cycles of 45 sec at 95°C, 45 sec at 65°C and 1 min at 72°C. The primers were designed by Primer 5.0 software (Premier Tech Ltd., Rivière-du-Loup, Canada) and synthesized by Invitrogen (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The primers and PCR conditions are specified in [Table II](#tII-etm-0-0-5582){ref-type="table"}. The product length was obtained from gene sequencing. The sequencing reactions were conducted by the Chinese National Human Genome Center (SinoGenoMax Co., Ltd., Beijing, China). DNA sequence analysis and variation identification were performed using DNAssist version 2.0, Chromas version 2.0 (Technelysium Pty., Ltd., South Brisbane, Australia) and the Basic Local Alignment Search Tool database (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). To identify whether the twins were monozygotic or dizygotic, short tandem repeat markers were analyzed on an ABI 3730XL DNA Analyzer (Thermo Fisher Scientific, Inc.) at the Gene Diagnosis Center of Zhongnan Hospital (Wuhan University).

### Statistical analysis

SPSS version 17.0 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Data were analyzed with a χ^2^ test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Pedigree analysis

The 4 families identified as having familial IBD in the present study had a total of 100 members, including 10 patients with IBD (8 patients with CD and 2 with UC). A total of 78 subjects (10 patients + 68 unaffected relatives) were interviewed directly, and the health histories of the remaining 22 unaffected relatives were acquired by telephone inquiry or from statements made by relatives. The pedigrees are illustrated in [Fig. 1](#f1-etm-0-0-5582){ref-type="fig"}. Family 1 had 2 patients with CD (a father and his daughter). Family 2 had 2 monozygotic twin brothers with CD. Family 3 had 4 cousins with CD (2 females and 2 males, two of whom were siblings). Family 4 had 2 sisters with UC. This pedigree analysis indicated that an autosomal recessive inheritance may have accounted for the disease in family 1; however, the other 3 families appeared to follow a pattern of polygenetic or multifactorial inheritance rather than single-gene inheritance.

### Clinical characteristics

The clinical characteristics of the 10 patients with familial IBD are summarized in [Tables III](#tIII-etm-0-0-5582){ref-type="table"} and [IV](#tIV-etm-0-0-5582){ref-type="table"}. The registered database at the Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases included 571 CD patients and 227 UC patients who were admitted between January 2002 and December 2013, with a 1.25% ratio of patients with a family history of IBD. Consistent with reports in the Western population, first-degree relatives were more susceptible to IBD and siblings were affected more frequently (10-fold increase) compared with the general population ([@b19-etm-0-0-5582]). Among the 4 families, the onset of IBD in the daughter of family 1 was 16 years earlier than her father\'s, and her infection was more severe and extensive, as CDAI scores were 11 and 4 for the daughter and father, respectively. In family 3, siblings were identified to have a high concordance of clinical type and location according to the location of the lesion, behavior and treatment. In all 4 families, the susceptibility was the same between males and females (5 male and 5 female). Among the couples investigated, there were no instances of both partners being affected by IBD.

The median age of onset was 29.0 years old for the 8 CD patients and 35.5 years old for the 2 UC patients. A previous study by our group observed that the median age of diagnosis was 36 years old for CD patients and 41 years old for UC patients in mainland China ([@b20-etm-0-0-5582]). In the present study, the median age of diagnosis was younger in familial patients compared with sporadic patients in China (data not shown).

A comparison between the familial and sporadic patients was performed using the data in our registered IBD database. The percentage of extraintestinal manifestations was 12.5% (1/8) of familial patients, which was similar to the previously reported result of 13.1% of sporadic patients ([@b21-etm-0-0-5582]). Among the 4 families, one CD patient (family 1 member 6, F1-III6) exhibited an extraintestinal manifestation of aphthous stomatitis. Of the 8 CD patients, 3 male CD patients (37.5%; F2-III5, F2-III6 and F3-III4) underwent surgical enterectomy, which was a similar percentage to that observed in a previous study (26.9%) ([@b22-etm-0-0-5582]). A total of 2 CD patients (F1-III6 and F2-III6) exhibited an acute and fulminant onset and 2 CD patients (F1-III6 and F2-III5) exhibited an anal fistula. A total of 4 CD (F1-II6, F2-III5, F2-III6, F3-II4) patients suffered severe attacks, while the other 4 CD patients (F3-III8, F3-III10, F3-III2, F1-II6) and 2 UC sisters (F4-III3, F4-III4) underwent a mild-moderate progression.

### Risk analysis of demographic factors

Selected demographic factors were compared between the patients and their unaffected family members. As depicted in [Table V](#tV-etm-0-0-5582){ref-type="table"}, the stressful life event of immigration to a new living place significantly increased the risk of IBD (odds ratio: 4.667; 95% confidence interval: 1.165--18.690; P=0.021). The confidence intervals of all the demographic factors was 95%. Other demographic factors, namely residence, education, labor intensity, marital status, smoking, history of other autoimmune diseases, vaccinations and possession of a pet animal were also evaluated; however, no significant correlations were observed (P\>0.05).

### Genotypes of selected loci

The 7 reported gene mutations associated with IBD ([Table I](#tI-etm-0-0-5582){ref-type="table"}) were screened in the familial patients. No patients carried any of the mutations. Nearby sequences within the same exon of the 7 loci were also evaluated (3rd and 4th exon of *IL10RA*; 4th exon of *IL10RB*; 1st exon of *XIAP*; and 4th, 8th and 11th exon of *NOD2*). No homozygous or heterozygous mutations were identified. Partial wild-type sequence chromatograms of these gene loci are depicted in [Fig. 2](#f2-etm-0-0-5582){ref-type="fig"}. Single-site mutations were observed in 7 genes, including *IL10R* Thr84, *IL10R* Gly141, *IL10R* Trp159, *XIAP* Cys203, *NOD2* Arg702, *NOD2* Gly908 and *NOD2* Leu1007.

Discussion
==========

A large number of patients with familial IBD have been reported in Western countries ([@b23-etm-0-0-5582],[@b24-etm-0-0-5582]). Halme *et al* ([@b25-etm-0-0-5582]) previously documented that the ratio of patients with a family history of IBD varied between 2--14%. Gearry *et al* ([@b26-etm-0-0-5582]) reported a family history prevalence rate of 33.2% in IBD. Furthermore, Ng *et al* ([@b27-etm-0-0-5582]) reported that the ratios of patients with a family history of IBD were 3 and 17% in Asia and Australia, respectively. In the present study, the ratio of patients with a family history of IBD was 1.25%, which was lower than those reported previously. The phenomenon of less familial clustering in the Chinese population has been discussed in a previous study ([@b28-etm-0-0-5582]). Other major findings concerning familial clustering in the present study were consistent with previous studies ([@b4-etm-0-0-5582],[@b29-etm-0-0-5582]). The present results indicated that offspring had an earlier onset and more severe infection than the parental generation. In addition, compared with sporadic patients, the median age of diagnosis was younger in familial patients.

Accumulating evidence suggests that genetic factors are involved in the development of IBD ([@b30-etm-0-0-5582]). A total of 7 mutations within 4 genes were investigated in the present study. Mutations in the *NOD2* gene (Arg702Trp, Gly908Arg and Leu1007fsinsC) have been widely studied and are typically associated with IBD in Caucasian individuals ([@b8-etm-0-0-5582],[@b31-etm-0-0-5582],[@b32-etm-0-0-5582]). It has been demonstrated that NOD-induced nuclear factor-κB may be dependent on XIAP through an indirect interaction between the baculoviral IAP repeats (BIR2) and receptor-interacting serine/threonine-protein kinase 2 (RIP2) ([@b33-etm-0-0-5582]--[@b35-etm-0-0-5582]). Furthermore, a previous study observed that a single mutation in the *XIAP* gene (Cys203Tyr) caused intractable IBD of a male child, which was cured by a hematopoietic progenitor cell transplant ([@b9-etm-0-0-5582]). In addition, XIAP has been implicated as a critical factor for toll-like receptor-modulated signaling in response to infection ([@b36-etm-0-0-5582]). Previous results have suggested that mutations in *IL10RA* (Thr84Ile and Gly141Arg) and *IL10RB* (Trp159X) may result in a loss of protein function and have been associated with hyperinflammatory reactions caused by intestinal bacteria ([@b10-etm-0-0-5582],[@b37-etm-0-0-5582],[@b38-etm-0-0-5582]). However, none of the 7 susceptibility mutations were detected in the familial patients of the present study. Inoue *et al* ([@b14-etm-0-0-5582]) also reported a lack of common *NOD2* variants in Japanese patients with CD, and Wang *et al* ([@b39-etm-0-0-5582]) reported that the common variants of *NOD2* had no correlation with IBD in the Zhejiang province of China ([@b39-etm-0-0-5582]). One of our previous studies indicated that the *NOD2* 3020insC frame-shift mutation did not contribute to the susceptibility of CD and UC in sporadic patients in central China ([@b40-etm-0-0-5582]). These results indicate that inconsistencies exist in different ethnic groups. Furthermore, a recent trans-ancestry association study of IBD demonstrated genetic heterogeneity between divergent populations ([@b41-etm-0-0-5582]).

In the present study, the stressful life event of immigration was a potential risk factor of IBD. Stress may alter the microenvironment of the intestinal tract ([@b42-etm-0-0-5582]). A previous study observed that fried food and stress were associated with an increased risk of IBD ([@b39-etm-0-0-5582]). However, diet information was not recorded in our database; therefore, the association between diet and IBD was not analyzed in the present study. These findings suggest that even for familial patients, environmental factors are involved in the pathogenesis of IBD, in addition to genetic background.

In China, the prevalence of IBD has increased markedly in the past two decades ([@b43-etm-0-0-5582],[@b44-etm-0-0-5582]). Compared with the Western population, less familial clustering is observed in the Chinese population ([@b28-etm-0-0-5582]). The one-child policy also makes it difficult to conduct family research in the Chinese population. These factors may explain the relatively small number of familial patients enrolled in the present study. However, to the best of our knowledge, the present study observed the first cases of concordant CD to occur in monozygotic twins in China. In addition, the electronic medical database enabled comparisons between familial and sporadic patients.

A number of limitations were included in the present study. Firstly, selection bias may have occurred, as the study was performed using a hospital-based registry instead of a population-based resource. However, universal health systems in China currently contain incomplete data on rural populations, which may result in some families with IBD being omitted from wide-scale population studies. Secondly, only 7 common genetic variants were tested, and no positive associations were identified. Other previously identified or unidentified genes may also contribute to disease progression in familial patients. For instance, the *DLG1* gene was recently identified as a potential gene associated with CD in Chinese patients ([@b45-etm-0-0-5582]). Two genome-wide association studies also identified a number of novel susceptibility loci in Japanese and Korean individuals ([@b46-etm-0-0-5582],[@b47-etm-0-0-5582]). Therefore, further studies with larger sample sizes and extensive coverage are required to map the susceptibility loci of IBD in the Chinese population.

In conclusion, the results of the present study indicated that the percentage of patients with a family history of IBD was 1.25%, which was lower than that reported previously. Furthermore, the present results indicated that offspring had an earlier onset and more severe infection compared with parents. In addition, the median age of diagnosis was younger in familial patients compared with sporadic patients. Genetic factors are involved in the development of IBD and immigration was identified as a potential risk factor for IBD due to alterations to the intestinal tract microenvironment. These findings suggest that the genetic background but and environmental factors are involved in the pathogenesis of IBD, even in familial patients.
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![Pedigrees of 4 Chinese families with inflammatory bowel disease. In family 1, a father and his daughter had CD. Family 2 had 2 monozygotic twin brothers with CD. Family 3 had 4 cousins with CD (2 females and 2 males, two of whom were siblings). Family 4 had 2 sisters with ulcerative colitis. Squares, male family members; circles, female family members; black, affected patients; gray, suspected patients; slashes, deceased family members; arrow, the first diagnosed patient of the family. CD, Crohn\'s disease.](etm-15-02-1367-g00){#f1-etm-0-0-5582}

![Partial wild-type sequence chromatograms of the 7 gene loci detected. (A) *IL10RA* Thr84; (B) *IL10RA* Gly141; (C) *IL10RB* Trp159; (D) *XIAP* Cys203; (E) *NOD2* Arg702; (F) *NOD2* Gly908; (G) *NOD2* Leu1007. The italicized letters indicate the mutation sites gene coding the coresponding proteins. IL10R, interleukin-10 receptor; XIAP, X-linked inhibitor of apoptosis; NOD2, nucleotide-binding oligomerization domain-containing protein 2.](etm-15-02-1367-g01){#f2-etm-0-0-5582}

###### 

Mutations screened in the study.

  Gene       Exon   Nucleotide change   Amino acid change
  ---------- ------ ------------------- -------------------
  *IL10RA*     3    (C\>T) 608          Thr84Ile
  *IL10RA*     4    (C\>A) 253          Gly141Arg
  *IL10RB*     4    (G\>A) 421          Trp159X
  *XIAP*       1    (G\>T) 608          Cys203Tyr
  *NOD2*       4    (C\>T) 2104         Arg702Trp
  *NOD2*       8    (G\>C) 2722         Gly908Arg
  *NOD2*     11     3020 insC           Leu1007sinsC

IL10R, interleukin-10 receptor; XIAP, X-linked inhibitor of apoptosis; NOD2, nucleotide-binding oligomerization domain-containing protein 2; A, adenine, T, thymine; G, guanine; C, cytosine; ins, insertion; X, stop codon.

###### 

Primers and polymerase chain reaction conditions.

  Wild-type gene (starting position)   Primers, 5′-3′                   Annealing temperature, °C   Product length, bp
  ------------------------------------ -------------------------------- --------------------------- --------------------
  *IL10RA* (608C)                      Forward: GGCCTCTTGCGTCTCCC       56                          359
                                       Reverse: GCAGACATGGTGAGCTATGG                                
  *IL10RA* (253C)                      Forward: ATTCTGGAGGCAAAGTCTCG    56                          348
                                       Reverse: AGTTCCCAATGGCACACAAG                                
  *IL10RB* (421G)                      Forward: CTACCCTTCTTAGCCATGTCA   56                          777
                                       Reverse: TCCGATCAGATCTTTTGACTC                               
  *XIAP* (608G)                        Forward: TTGAGAACTGGGCAGGTTGT    59                          179
                                       Reverse: CACTGCACTTGGTCACCAAT                                
  *NOD2* (2104C)                       Forward: CTCCGCAAGCACTTCCACTC    59                          280
                                       Reverse: CCACGCCAATGTCACCCAC                                 
  *NOD2* (2722G)                       Forward: GAGGAGGACTGTTAGTTCATG   57                          290
                                       Reverse: TTCCTTACTCCATTGCCTA                                 
  *NOD2* (3020T)                       Forward: TGGTACTGAGCCTTTGTT      57                          461
                                       Reverse: GAAATCATTGCTCCCTACT                                 

IL10R, interleukin-10 receptor; XIAP, X-linked inhibitor of apoptosis; NOD2, nucleotide-binding oligomerization domain-containing protein 2; C, cytosine; G, guanine; T, thymine.

###### 

Clinical characteristics of the Crohn\'s disease patients.

  Case       Year of birth   Sex   Year of onset   Year of diagnosis   Location of lesion                                                                     Disease phenotype                   Treatment                                                         EIM   Surgery   CDAI
  ---------- --------------- ----- --------------- ------------------- -------------------------------------------------------------------------------------- ----------------------------------- ----------------------------------------------------------------- ----- --------- ------
  F1-II6     1968            M     2000            2002                Terminal ileum + rectum                                                                Stricturing                         Mesalazine + corticosteroids                                      No    No        4
  F1-III6    1996            F     2012            2012                Terminal ileum + ileocecus + ascending colon + rectum + upper gastrointestinal tract   Penetrating                         Mesalazine + corticosteroids + biological agents + azathioprine   Yes   No        11
  F2-III5    1981            M     2004            2006                Terminal ileum + ileocecus + rectum                                                    Stricturing                         Mesalazine + corticosteroids + azathioprine                       No    Yes       9
  F2-III6    1981            M     2009            2009                Terminal ileum + ileocecus                                                             Stricturing                         Mesalazine + corticosteroids + biological agents + azathioprine   No    Yes       11
  F3-III2    1973            M     2013            2013                Terminal ileum + ileocecus                                                             Non-penetrating + non-stricturing   Mesalazine                                                        No    No        1
  F3-III4    1975            M     2009            2010                Terminal ileum + ileocecus + rectum                                                    Penetrating                         Mesalazine + corticosteroids + azathioprine                       No    Yes       11
  F3-III8    1987            F     2012            2012                Terminal ileum + ileocecus + rectum                                                    Non-penetrating + non-stricturing   Mesalazine                                                        No    No        6
  F3-III10   1979            F     2013            2013                Terminal ileum + ileocecus                                                             Non-penetrating + non-stricturing   Mesalazine                                                        No    No        1

F1, family 1; F2, family 2; F3, family 3; M, male; F, female; EIM, extraintestinal manifestations; CDAI, Crohn\'s disease activity index.

###### 

Clinical characteristics of the ulcerative colitis patients.

  Case      Year of birth   Sex   Year of onset   Year of diagnosis   Location of lesion                          Treatment                      UCAI
  --------- --------------- ----- --------------- ------------------- ------------------------------------------- ------------------------------ ------
  F4-III3   1972            F     2008            2010                Descending colon + sigmoid colon + rectum   Mesalazine + corticosteroids   8
  F4-III4   1974            F     2009            2010                Descending colon + sigmoid colon + rectum   Mesalazine + corticosteroids   8

F4, family 4; F, female; UCAI, ulcerative colitis activity index.

###### 

Comparison of demographic factors between familial patients and interviewed unaffected relatives.

  Factor                                 IBD (n=10)   Unaffected (n=68)   Odds ratio   P-value
  -------------------------------------- ------------ ------------------- ------------ ---------
  Residence                                                               0.929        0.915
    City                                 6            42                               
    Town                                 4            26                               
  Immigration before diagnosis           5            12                  4.667        0.021
  Education                                                               1.826        0.632
    High school or below                 6            46                               
    University or college                4            22                               
  Occupation                                                                           0.941
    Student                              1            6                   1.481        
    Manual worker                        4            24                  1.267        
    Mental worker                        5            38                               
  Marital status                                                          1.222        0.772
    Single                               4            24                               
    Married                              6            44                               
  Current smoker                         1            18                  0.309        0.257
  History of other autoimmune diseases   0            3                   0            0.498
  Vaccinations                           5            43                  0.581        0.422
  Pet animal                             3            22                  0.986        0.882

IBD, inflammatory bowel disease.
